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Abstract
Staphylococcus aureus colonization and infection occur more commonly among persons living or working in crowded
conditions, but characterization of S. aureus colonization within medical communities in China is lacking. A total of 144
(15.4%, 144/935) S. aureus isolates, including 28 (3.0%, 28/935) MRSA isolates, were recovered from the nares of 935 healthy
human volunteers residing on a Chinese medical college campus. All S. aureus isolates were susceptible to vancomycin,
quinupristin/dalfopristin and linezolid but the majority were resistant to penicillin (96.5%), ampicillin/sulbactam (83.3%) and
trimethoprim/sulfamethoxazole (93.1%). 82%, (23/28) of the MRSA isolates and 66% (77/116) of the MSSA isolates were
resistant to multiple antibiotics, and 3 MRSA isolates were resistant to mupirocin—an agent commonly used for nasal
decolonization. 16 different sequence types (STs), as well as SCCmec genes II, III, IVd, and V, were represented among MRSA
isolates. We also identified, for the first time, two novel STs (ST1778 and ST1779) and 5 novel spa types for MRSA. MRSA
isolates were distributed in different sporadic clones, and ST59-MRSA-VId- t437 was found within 3 MRSA isolates. Moreover,
one isolate with multidrug resistance belonging to ST398-MRSA-V- t571 associated with animal infections was identified,
and 3 isolates distributed in three different clones harbored PVL genes. Collectively, these data indicate a high prevalence of
nasal MRSA carriage and molecular heterogeneity of S. aureus isolates among persons residing on a Chinese medical college
campus. Identification of epidemic MRSA clones associated with community infection supports the need for more effective
infection control measures to reduce nasal carriage and prevent dissemination of MRSA to hospitalized patients and health
care workers in this community.
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Introduction
Staphylococcus aureus is one of the most prevalent and clinically
significant pathogens worldwide, causing a variety of illnesses
ranging from benign, superficial skin eruptions to life-threatening
infections with bacteraemia, endocarditis, pneumonia and toxic
shock syndrome [1]. Since methicillin-resistant S. aureus (MRSA)
was first identified in 1961, it has become the most common cause
of nosocomial and community infections worldwide [2]. The
recent emergence of highly virulent community-associated MRSA
(CA-MRSA) isolates which cause disease in individuals with no
apparent risk factors for hospital acquisition of MRSA has raised
widespread concern over how CA-MRSA is transmitted in the
community setting [3,4].
S. aureus is a member of commensal microflora and readily
colonizes the anterior nares in humans. Many infections caused by
S. aureus occur in persons with prior nasal carriage [5], and this
carriage is an important risk factor for nosocomial S. aureus
infection in patients undergoing surgery, hemodialysis, implanta-
tion of intravascular devices, and among HIV-infected patients
[6]. One study revealed that nasal carriage of S. aureus is an
important source of S. aureus bacteremia [7], and eliminating nasal
carriage of S. aureus may prevent systemic S. aureus infection [7].
Determination of the prevalence of S. aureus nasal carriage, as well
as antimicrobial resistance profiles and molecular typing for nasal
S. aureus isolates, in healthy populations is beneficial for identifying
risk factors associated with S. aureus infection [8,9,10]. Molecular
typing of S. aureus is also helpful for supporting infection control
measures, investigating suspected outbreaks and preventing
nosocomial transmission [11]. Identification of (Panton-Valentine
Leukocidin) PVL genes, pulsed-field gel electrophoresis (PFGE),
staphylococcal cassette chromosome mec (SCCmec) typing, spa
typing, and multilocus sequence typing (MLST) have been used to
monitor the evolutionary process of pandemic clones [12].
However, studies characterizing S. aureus isolates in China have
largely focused on isolates recovered from clinical specimens in the
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China showed that 63% of S. aureus isolates were MRSA,
including 77% of nosocomial isolates and 43% of community
isolates [13]. In addition, two major epidemic MRSA clones,
ST239-MRSA-SCCmec type III and ST5-MRSA-SCCmec type
II, are distributed across China in unique geographic patterns
[14]. These data suggest that dissemination of virulent MRSA
clones among healthy persons in China may contribute to the
presence of clinically significant MRSA infections in some
locations. To our knowledge, there are limited published studies
characterizing MRSA isolates recovered from nares of healthy
individuals in China who work and reside in the health care
setting. Therefore, we sought to determine the prevalence,
antimicrobial resistance profiles, and molecular characteristics
of nasal S. aureus isolates from students on a large medical college
campus in China.
Materials and Methods
Isolation and identification of nasal S. aureus isolates
935 volunteers from the campus of Wenzhou Medical College
in Wenzhou, Southeast China without symptoms or signs of
clinical illness were enrolled in the study over a one-month time
period. The healthy volunteers included had not used antibiotics
in past two months. Samples were collected from both anterior
nares of volunteers by rotating a sterile polyester fiber-tipped swab
moistened with sterile saline. Swabs were placed in 3 mL of Luria-
Bertani broth and transported to the Department of Clinical
Microbiology of the first Affiliated Hospital of Wenzhou Medical
College. Gram-positive, catalase-positive, coagulase-positive iso-
lates were confirmed as S. aureus using a Vitek-60 microbiology
analyzer (bioMe’rieu, Marcy l’Etoile, France). The Ethics
Committee of the first Affiliated Hospital of Wenzhou Medical
College exempted this study from review because the present study
focused on bacteria.
Susceptibility testing
S. aureus susceptibility to penicillin (10 mg), ampicillin/sulbactam
(20/10 mg), cefazolin (30 mg), vancomycin (30 mg), erythromycin
(15 mg), clindamycin (2 mg), rifampicin (5 mg), linezolid (30 mg),
mupirocin (5 mg), quinupristin/dalfopristin (15 mg), tetracycline
(30 mg), trimethoprim/sulfamethoxazole (1.25/23.75 mg), genta-
micin (10 mg), ciprofloxacin (5 mg), and levofloxacin (5 mg) were
determined using the disk diffusion method in accordance with
standards recommended by the Clinical and Laboratory Stan-
dards Institute (CLSI) [15]. All disks were obtained from Oxoid
Ltd., and S. aureus ATCC 25923 was used as a quality control
strain. Susceptibility of S. aureus to mupirocin was also determined
using disk diffusion, with a zone diameter $14 mm using a 5-mg
disc indicating susceptibility as described previously [16]. MICs of
mupirocin for mupirocin-resistant isolates were further determined
by the agar dilution method in accordance with the CLSI
guidelines [15]. mupA was detected among mupirocin-resistant
isolates as described previously[17].
DNA Extraction
S. aureus isolates were cultured on blood agar overnight. Three
to four bacterial colonies were suspended in 150 mL sterile distilled
water with lysostaphin (1 mg/mL) (Sangon, China) and incubated
at 37uC for 30 min. DNA was extracted using the Genomic DNA
Extraction kit according to the manufacturer’s instructions
(Sangon, China). DNA was stored at 220uC and prepared for
PCR amplification.
Detection of MRSA and PVL genes
A multiplex PCR protocol described previously was used for
simultaneous amplification of mecA, 16S rRNA, and PVL genes
[18]. Isolates harboring mecA were confirmed as MRSA using
MRSA N315 as a positive control strain.
SCCmec typing
SCCmec typing of MRSA isolates was performed using eight
unique and specific pairs of primers for SCCmec types and
subtypes I, II, III, IVa, IVb, IVc, IVd, and V as described
previously [19]. The MRSA isolates with unexpected fragments or
lacking fragments by multiplex PCR were defined as non-typeable
(NT). MRSA NCTC 10442 (SCCmecI), MRSA N315 (SCCmec II),
MRSA 85/2082 (SCCmec III), MRSA JCSC 4744 (SCCmec IV)
and MRSA WZ153 (SCCmec V) were used for positive controls.
spa typing
The spa variable repeat region from each MRSA isolate was
amplified by simplex PCR oligonucleotide primers as previously
described [20,21]. Purified spa PCR products were sequenced, and
spa types were assigned by using the spa database website (http://
www.ridom.de/spaserver).
Multilocus sequence typing (MLST)
MLST of MRSA isolates was conducted through amplification
of internal fragments of the seven housekeeping genes of S. aureus
as described previously [22]. Following purification and sequenc-
ing of these genes, allele quantification and sequence typing were
assigned using a well-characterized online database (http://
saureus.mlst.net/). The DNA sequences of novel STs were verified
by Pro. Enright and deposited in MLST database.
Results
A total of 144 S. aureus isolates were isolated from the nares of
the 935 volunteers in the study. The nasal carriage rate of S. aureus
was 15.4% (144/935). 19.4% (28/144) of S. aureus isolates were
identified as MRSA. The prevalence of nasal MRSA carriage was
3.0% (28/935). The resistance profiles of MRSA, MSSA and S.
aureus isolates to antimicrobials tested were listed in Table 1. All S.
aureus isolates tested were susceptible to vancomycin, quinupristin/
dalfopristin and linezolid. The majority of S. aureus isolates were
resistant to penicillin (96.5%), ampicillin/sulbactam (83.3%) and
trimethoprim/sulfamethoxazole (93.1%). Isolates displayed com-
plete or intermediate levels of resistance to gentamicin (16.0% and
18.1%), tetracycline (28.5% and 16.7%), ciprofloxacin (23.6% and
22.2%), clindamycin (31.2% and 23.6%) and erythromycin
(52.1% and 30.6%). The resistance rates of MRSA isolates to
gentamicin, ciprofloxacin, levofloxacin, erythromycin and clinda-
mycin were significantly higher than those among MSSA isolates
(Table 1). However, the intermediate resistance rates of MSSA
isolates to gentamicin, tetracycline, erythromycin, clindamycin
and rifampicin were higher than for MRSA isolates (Table 1).
82.1% (23/28) of MRSA isolates and 66.4% (77/116) of MSSA
isolates were resistant to at least 3 different antimicrobials tested.
Three MRSA isolates with no zone of inhibition to mupirocin
(2.1%, 3/144) were resistant to mupirocin. The mupirocin MICs
for the 3 MRSA isolates were .512 mg/mL determined by agar
dilution method. The 3 MRSA isolates were positive for mupA
detected by PCR.
MRSA isolates expressing SCCmec V (15 isolates), SCCmec II (5
isolates), SCCmec III (4 isolates) and SCCmec IVd (3 isolates) were
identified (Table 2). The remaining isolate was non-typeable by
multiplex PCR. MLST revealed 16 different sequence types (STs)
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ST88, ST188, ST338, ST438,ST398, ST943, ST946, ST1295,
ST1556, ST1623, ST1778 and ST1779 were identified (Table 1).
Since at least one of the 7 housekeeping genes for MLST typing
could not be amplified among the remaining 6 MRSA isolates,
STs for these isolates were not available. The STs most commonly
identified were ST59 (4 isolates), ST25 (3 isolates), ST188 (2
isolates) and ST438 (2 isolates). Two novel STs recently deposited
in the MLST database (http://saureus.mlst.net/), ST1778 and
ST1779, were also identified.
19 MRSA isolates were assigned 12 previously characterized spa
types, and 5 other isolates were assigned 5 novel spa types (Table 2).
spa typing could not be assigned for the remaining 5 MRSA
isolates. Furthermore, MRSA isolates were distributed among
different sporadic clones. ST59-MRSA-VId-spa t437 was identi-
fied for 3 MRSA isolates. Three isolates, representing ST1556-
MRSA-V- t437, ST25-MRSA-NT- t078 and ST338-MRSA-V-
t163 clones, harbored PVL genes. One isolate exhibiting
multidrug resistance was characterized as an ST398-MRSA-V-
spa t571 clone. Three MRSA isolates typed as ST25 exhibited
different spa types and SCCmec types and belonged to different
clones. Although 2 ST188 MRSA isolates harbored SCCmec (V),
these isolates exhibited two different spa types, t189 and t1751.
Discussion
The prevalence of S. aureus nasal carriage among healthy adults
ranges from approximately 20% to 30%, with higher prevalences
in overcrowded populations [5,6,8,23]. In the United States, a
national population-based survey conducted over a 3-year period
revealed nasal S. aureus colonization for 32% of study participants
[24]. In contrast, a relatively low rate of nasal S. aureus carriage
(6.3%) was found for children under the age of 5 in India [25].
The prevalence of nasal colonization with S. aureus in our study
was 15.4%, a prevalence similar to that observed (16%) for a
suburban military camp cohort in Beijing, China [26]. However,
the prevalence of nasal MRSA carriage in our study (3.0%) was
higher than prevalences previously reported for cohorts from
developed countries, including the United States [24,27,28].
Furthermore, no nasal MRSA colonization was found among
Chinese healthy military volunteers in another study [26]. In
contrast, a relatively high prevalence of MRSA colonization was
found (11.6%) for a cohort of healthy children aged #14 years in
community settings in Taiwan over a 5-year period [29]. These
data indicate that MRSA colonization varies significantly, even
within similar populations in developed countries. The isolation of
nasal S. aureus with a single sample may result in underestimating
the number of intermittent carriers. In order to improving the
isolation of nasal S. aureus, multiple nasal swabs should be taken
from both anterior nares of volunteers. Additional studies are
needed to clarify relationships between MRSA colonization, age,
general antibiotic use, and other variables within overcrowded
populations at higher risk for MRSA infections.
Our study revealed that 93% of nasal S. aureus isolates were
resistant to trimethoprim-sulfamethoxazole, with MSSA isolates
exhibiting the highest rates of resistance. These data contradict
several studies reporting low rates of resistance to trimethoprim-
sulfamethoxazole for S. aureus isolates recovered from the nares
[29–31]. For example, in one study of 371 nasal S. aureus isolates,
only 7 (1.9%) were resistant to trimethoprim-sulfamethoxazole
[29]. Our data are not in agreement with another study reporting
trimethoprim-sulfamethoxazole susceptibility rates of 78.6% and
95.3%, for MRSA and MSSA isolates, respectively, recovered
from patients in 12 cities across China [30]. Similar to other
surveillance studies [13,30], we found high rates of resistance for
nasal S. aureus isolates to penicillin, ampicillin/sulbactam and
erythromycin, and no discernable resistance of these isolates to
vancomycin, quinupristin/dalfopristin or linezolid. Mupirocin is
used commonly for treating MRSA skin and soft-tissue infections
and eliminating nasal MRSA colonization among patients and
medical staff. Our study indicated that 10.7% of nasal MRSA
isolates were resistant to mupirocin, in agreement with mupirocin
resistance rates observed for MRSA isolates recovered in the
context of clinical infection in another study conducted in
Table 1. Antimicrobial susceptibility profiles of MRSA, MSSA and S. aureus nasal isolates.
MRSA (n=28)
a MSSA(n=116) S. aureus(n=144)
R(%) I(%) R(%) I(%) R(%) I(%)
penicillin 100 95.7 96.5 0
Ampicillin/Sulbactam 92.9 82.8 83.3 1.4
cefazolin 7.1 7.1 0.9 0 2.1 1.4
trimethoprim/sulfametho-xazole 85.7 0 94.8 0 93.1 0
gentamycin 28.6 7.1 12.9 20.7 16.0 18.1
tetracycline 28.6 0 28.4 20.7 28.5 16.7
vacomycin 0 0 0 0 0 0
ciprofloxacin 53.6 17.9 16.4 23.3 23.6 22.2
levofloxacin 39.3 17.9 6.9 6.0 13.2 8.3
erythromycin 75 14.3 46.6 34.5 52.1 30.6
clindamycin 53.6 10.7 25.9 27.6 31.2 23.6
rifampicin 3.6 0 6.9 8.6 6.3 6.9
L i n e z o l i d 0000 00
dalfopristin/quinupristin 0 0 0 0 0 0
mupirocin 10.7 0 0 0 2.1 0
a: R, resistance; I, intermediate susceptibility.
doi:10.1371/journal.pone.0027328.t001
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egies including mupirocin may prove more successful for reducing
nasal MRSA carriage among members of the Chinese medical
community, and possibly Chinese hospital-associated MRSA
infections.
Understanding the molecular characteristics of MRSA isolates
recovered from healthy individuals may facilitate a better
understanding of mechanisms for geographic distribution of
MRSA in certain populations, as well as the population-based
risk for aggressive community-acquired MRSA infections. CA-
MRSA isolates from different geographic areas have demonstrated
significant genetic diversity [12]. The vast majority of CA-MRSA
isolates worldwide belong to 5 clones: pandemic clone USA300
(ST8), European clone (ST80), midwest clone (ST1), southwest
pacific oceanic clone (ST30) and pacific clone (ST59) [12]. Studies
performed in Taiwan indicate that ST59 was the most common
MLST type for MRSA isolates associated with community-
acquired infections and nasal colonization, particularly pediatric
infections [29,32,33,34]. The majority (90%) of MRSA isolates
recovered from healthy individuals over a 5-year period in Taiwan
were clustered into minor variants of two clonal types, ST59 and
ST338 [29]. However, the nasal MRSA isolates recovered in our
study showed considerable heterogeneity, with ST59 and ST338
accounting for only 14.3% and 3.6% of STs, respectively. One
recently published study found that among MRSA isolates
associated with pediatric infections on the Chinese mainland,
ST59-MRSA-SCCmecVI-t437 was the most common clone
identified (59%), followed by ST1 (8%) and ST338 (8%) [35].
ST59-MRSA-SCCmecVI-t437 and ST338-MRSA-SCCmecV-
t163 clones were identified from healthy volunteers in our study,
indicating that these two clones may contribute to community
infection and dissemination among hospital employees. HA-
MRSA infections are caused by a relatively small number of
epidemic MRSA clones [36], and ST239-MRSA-SCCmec type III
and ST5-MRSA-SCCmec type II are two major epidemic MRSA
clones identified in China [14]. Interestingly, these two clones
were not isolated in our study. In previous studies published by our
group [37,38], ST88 was the most common clone identified
among PVL-positive isolates. In the present study, ST88-MRSA-
SCCmecV was identified for only one PVL-negative nasal MRSA
isolate. Whether CA-MRSA clones identified within the nares of
healthy individuals are responsible for clinical infections caused by
CA-MRSA in China remains to be determined.
CA-MRSA pathogenesis has been linked to carriage of PVL
encoding genes [39]. Relatively high prevalences of PVL gene
expression were also found among nasal S. aureus isolates in
Chengdu, China (22%) [41], and Taiwan (19.1%) [40,41]. We
noted a somewhat lower prevalence (11%) of PVL gene expression
for nasal MRSA isolates in our study. Whether a higher
prevalence of PVL expression for nasal S. aureus isolates portends
a higher rate of clinical S. aureus infections, and more severe CA-
MRSA infections, in Chinese populations remains to be
determined. Epidemiologic studies tracking incident CA-MRSA
infections in our institution, and determining whether infections
caused by PVL-expressing CA-MRSA isolates arise in persons in
contact with healthy volunteers in our study harboring these
isolates, is ongoing.
ST398-MRSA is usually associated with animal infection,
especially in pigs [42], and persons in close contact with animals
are more likely to harbor ST398-MRSA isolates [37,43,44,45].
Recently published data suggest that human infections caused by
MRSA-ST398 are increasing [37,43,44,45]. One nasal MRSA
isolate belonging to ST398-MRSA-V-spa t571 was found in our
study. It would be interesting to determine whether medical
students performing cadaveric procedures using animals are more
likely to harbor ST398-MRSA.
In conclusion, we found a relatively high prevalence of nasal
MRSA carriage within healthy persons from a Chinese medical
college campus. Among these nasal MRSA isolates, epidemic
clones associated with community infection were found, support-
ing policies for reducing nasal carriage in order to prevent spread
of MRSA to community members and hospitalized patients.
Moreover, antibiotic resistance patterns for these isolates indicate
that unique decolonization strategies may be needed.
Acknowledgments
We gratefully acknowledge the students from Wenzhou Medical College,
Zhongyong Wang and Liqing Zhu, for participation in the collection of
nasal specimens and Yuanyuan Lu for performing experiment. We are also
grateful to T. Ito for the kind gift of MRSA NCTC 10442 (SCCmec I),
MRSA N315 (SCCmec II), MRSA85/2082 (SCCmec III), and MRSA
JCSC4744 (SCCmec IV).
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and their antibiotic resistance profiles.
SCCmec spa type STs Resistance profile
a pvl
b
N2 V t437 1556 P,AML,CIP +
N18 V t163 338 P,AML,SXT,E,DA,TE,RD +
N30 VId t437 59 P,AML,STX,E,KE 2
N39 V NT 438 P,AML,SXT,E,DA,CIP,LEV 2
N44 V t289 943 P,AML,SXT,E 2
N54 V new 88 P,AML,E,DA,CIP,LEV,CN,TE 2
N55 VId t437 59 P,AML,E,DA 2
N57 V t177 438 P,AML,SXT,E,DA,CIP,LEV,CN,TE 2
N58 II new NT
c P,AML,SXT,E, DA,CIP,CN,TE 2
N77 II new NT P,AML,SXT,E,DA,CIP,LEV,CN,TE 2
N86 V t571 398 P,AML,SXT,E,DA,CIP,CN 2
N91 III t304 59 P,AML,SXT 2
N92 III t304 NT P,AML,SXT,E,DA,CIP,LEV, MUP 2
N97 VId t437 59 P,AML,SXT,E,DE,TE 2
N98 V new 946 P,AML,SXT,E,DA 2
N99 III NT 6 P,SXT,DA 2
N108 V t189 188 P,AML,SXT 2
N112 II t081 NT P,AML,SXT,E, DA, CIP,LEV 2
N114 V t081 25 P,AML, SXT,E,CN,TE 2
N121 V NT 1778 P,AML,SXT,E,DA,CIP,LEV,CN,TE 2
N123 V NT 1623 P,AML,SXT,CIP,CN,KZ 2
N128 NT t078 25 P,AML,SXT,E +
N135 III t062 1779 P,AML,E,CIP,LEV 2
N145 V t1751 188 P,AML,SXT,E,CIP,LEV 2
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rifampicin; CN, gentamycin; KZ, cefazolin; TE, tetracycline; MUP, mupirocin.
b2, pvl negative; +, pvl positive.
cNT, not typeable.
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